Zilico support access to vital cervical cancer screening

Monday 18th November 2019


Manchester-based medical technology company Zilico Ltd are ensuring that women living in remote areas of the UK who need a colposcopic examination benefit from ZedScan™, a diagnostic device that improves the detection and diagnosis of cervical cancer.

Identifying 96% of high-grade precancerous disease in the cervix, ZedScan, when used as an adjunct during a standard colposcopy examination, can significantly improve patient outcomes.1 The non-visual technique allows for earlier detection of disease and therefore enables healthcare practitioners to take appropriate clinical intervention, which can prevent disease from progressing to cervical cancer.

Recently, Zilico’s Clinical Trainer and Nurse Colposcopist, Alison Roberts RGN, travelled from the UK to the Falkland Islands to carry out colposcopy examinations with ZedScan at King Edward VII Memorial Hospital, Stanley.

Many women living in the Falkland Islands have good local access to cervical screening, but those women referred to colposcopy are then required to travel to the UK for further examination and/or treatment, due to the absence of trained colposcopists and limited access to diagnostic equipment.2 This adds further stress to the women and the whole process also becomes time-consuming and costly for the health services.2

Dr Rebecca Edwards, Chief Medical Officer at King Edward VII hospital said, “It was a pleasure to have Alison here working with us and we were excited to learn about ZedScan and how it will support our services going forward with the new screening programme.”

Alison has already been able to carry out colposcopy examinations and treatments on three patients and advised on the follow up care for a further three women, without the need for them to travel to the UK. Using ZedScan as part of the examination has enabled Alison to make an informed decision about the patients’ clinical management. Alison hopes to continue to visit the Falkland Islands to provide support and training and screening pathway education for the medical teams on an annual basis.

Meanwhile, the Gilbert Bain Hospital, in the Shetland Isles which sees around 120 women a year referred to colposcopy, have also incorporated ZedScan into their services, reflecting the ongoing uptake of the device across Scotland. A colposcopy nurse from Aberdeen Royal Infirmary will be travelling once a month to the Gilbert Bain Hospital to carry out examinations with ZedScan and perform any treatments needed. 

ZedScan is now in routine use across many NHS England and NHS Scotland hospitals, with adoption and active evaluations across several countries in Europe and South America, including Poland, Finland, France, Netherlands, Greece and Mexico.

Sameer Kothari, CEO said: “We are extremely pleased to be part of these programmes and expand the work we are doing to improve early detection of cervical disease. Being able to provide an objective and immediate assessment supports the clinician’s visual inspection and ensures better outcomes for the patient and positive health economics for health services.”